Skip to content
Screener

Sionna Therapeutics SION Return on invested capital

Return on invested capital at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
28.4%+1.4pp
AbbVie logo
AbbVieABBV
17.1%
Achieve Life Sciences logo
Achieve Life SciencesACHV
-852.7%
Septerna, Inc. logo
Septerna, Inc.SEPN
-16.2%
RFL
Rafael Holdings, Inc.RFL
-109.2%-147pp
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
-51.1%-5.5pp

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$203.46M-77.0%
Enterprise value$147.55M-82.7%

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Calculated from Sionna Therapeutics’s reported figures.

Based on trailing twelve months.

The source filing: Sionna Therapeutics’s 10-Q, filed May 12, 2026. Open the filing →

Filed
May 12, 2026, 7:17 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-033876

FAQ

What is Sionna Therapeutics's return on invested capital?
Sionna Therapeutics (SION) reported return on invested capital of -38.8% in Q1 2026.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.

Ask your AI about Sionna Therapeutics's return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude